Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD – real-life experience from an observational study
Karina Jahnz-Różyk,1 Pawel Szepiel2 1Department of Immunology and Clinical Allergology, Military Institute of Medicine, Warsaw, Poland; 2Boehringer Ingelheim Sp. z o.o., Warsaw, Poland Background: Long-acting inhaled bronchodilators, including anticholinergic tiotropium, are recommended...
Main Authors: | Jahnz-Różyk K, Szepiel P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-03-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/early-impact-of-treatment-with-tiotropium-long-acting-anticholinergic--peer-reviewed-article-COPD |
Similar Items
-
Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis
by: Halpin DMG, et al.
Published: (2015-02-01) -
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
by: Feldman G, et al.
Published: (2016-04-01) -
Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01) -
Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study [Erratum]
by: Minakata Y, et al.
Published: (2019-09-01) -
Medical embryology in 115 minutes – surely not?
by: Wilson DJ
Published: (2019-04-01)